2021
DOI: 10.3390/jcm10112442
|View full text |Cite
|
Sign up to set email alerts
|

Ratio between Right Ventricular Longitudinal Strain and Pulmonary Arterial Systolic Pressure: Novel Prognostic Parameter in Patients Undergoing Cardiac Resynchronization Therapy

Abstract: Background: We aimed to evaluate whether right ventricle (RV) longitudinal strain indexed to pulmonary arterial systolic pressure (PASP) has prognostic significance in patients undergoing cardiac resynchronization therapy (CRT). Methods: Patients undergoing CRT were prospectively included. The primary endpoint was adverse cardiovascular events (death and HF-related hospitalizations). RV global longitudinal strain (RVGLS) and RV free wall strain (RVfwS) were measured by speckle tracking and indexed to echocardi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…RVFWLS/PASP and RVGLS/PASP predicted cardiac resynchronization therapy (CRT) response and adverse events after CRT in HF with reduced EF (HFrEF) (sensitivity 80% and specificity 77% for both). 39 In 315 stable outpatients with chronic HF (LVEF < 45%), RVFWLS/PASP and RVGLS/PASP appeared superior to TAPSE/PASP in predicting mortality. 40 In patients with HFrEF treated with sacubitril/valsartan, improvement in RV–PA coupling, indicated by TAPSE/PASP, was accompanied by improvement of right‐ and left‐sided cardiac parameters over 12 and 24 month follow‐up periods.…”
Section: Non‐invasive Surrogates Of Right Ventricular–pulmonary Arter...mentioning
confidence: 92%
See 1 more Smart Citation
“…RVFWLS/PASP and RVGLS/PASP predicted cardiac resynchronization therapy (CRT) response and adverse events after CRT in HF with reduced EF (HFrEF) (sensitivity 80% and specificity 77% for both). 39 In 315 stable outpatients with chronic HF (LVEF < 45%), RVFWLS/PASP and RVGLS/PASP appeared superior to TAPSE/PASP in predicting mortality. 40 In patients with HFrEF treated with sacubitril/valsartan, improvement in RV–PA coupling, indicated by TAPSE/PASP, was accompanied by improvement of right‐ and left‐sided cardiac parameters over 12 and 24 month follow‐up periods.…”
Section: Non‐invasive Surrogates Of Right Ventricular–pulmonary Arter...mentioning
confidence: 92%
“…Ever since TAPSE/PASP was introduced as a prognostic factor in HF, non‐invasive surrogate measures of RV–PA coupling have been extensively evaluated in many left‐sided cardiac pathologies. RVFWLS/PASP and RVGLS/PASP predicted cardiac resynchronization therapy (CRT) response and adverse events after CRT in HF with reduced EF (HFrEF) (sensitivity 80% and specificity 77% for both) 39 . In 315 stable outpatients with chronic HF (LVEF < 45%), RVFWLS/PASP and RVGLS/PASP appeared superior to TAPSE/PASP in predicting mortality 40 .…”
Section: Non‐invasive Surrogates Of Right Ventricular–pulmonary Arter...mentioning
confidence: 99%
“…RV-to-arterial coupling was estimated as the ratio between TAPSE or RV GLS and sPAP. Cut-off values ≤0.31 mm/mmHg or ≤0.35%/mmHg, respectively, were used to define RV uncoupling, as previously described [ 5 , 22 ]. Left chamber (size and function) quantification was assessed as previously described [ 17 , 19 ].…”
Section: Methodsmentioning
confidence: 99%
“…Besides TAPSE, tricuspid annular lateral wall peak systolic velocity (S′), RV fractional area change, RV ejection fraction (RVEF), RV global longitudinal strain, and RV free wall strain are echocardiographic parameters used to evaluate RV systolic function, and their ratio to PASP could similarly symbolize RV–PA coupling 33,38–42 . TAPSE/PASP was the sole non‐invasive marker of RV–PA coupling that independently correlated with Ees/Ea determined using invasive methods 19,39,43,44 ; therefore, it has great potential and is already frequently used in clinical settings 24,45–50 .…”
Section: Assessment Of Right Ventricular–pulmonary Arterial Couplingmentioning
confidence: 99%
“…Patients with HFrEF can benefit from cardiac resynchronization therapy (CRT) 74 . Several recent studies show that the TAPSE/PASP ratio can serve as a predictive tool to assess a patient's potential response to CRT 38,75 . Low TAPSE/PASP was associated with a greater likelihood of cardiac events and an inferior response to CRT 76 .…”
Section: Tricuspid Annular Plane Systolic Excursion/pulmonary Artery ...mentioning
confidence: 99%